ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Long-term debt, current

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndLong-term debt, current (Million USD)YoY (%)
Dec 31, 20253,033+102.20%
Dec 31, 20241,500+38.89%
Dec 31, 20231,080-52.02%
Dec 31, 20222,251+198.54%
Dec 31, 2021754+10671.43%
Dec 31, 20207-99.45%
Dec 31, 20191,277+18142.86%
Dec 31, 20187-98.62%
Dec 31, 2017508+16833.33%
Dec 31, 20163+0.00%
Dec 31, 20153-66.67%
Dec 31, 20139-99.12%
Dec 31, 20111,027-49.78%
Dec 31, 20102,045

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat